lorazepam has been researched along with chloral hydrate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Getson, A; Kramer, MS; Last, B; Reines, SA | 1 |
| Ator, NA; Griffiths, RR | 1 |
| Coté, J; McPherson, C; Peters, K; Tyebkhan, J | 1 |
| Agrawal, D; Gupta, R; Krauss, B; Manzi, SF | 1 |
| da Silva, PS; Passos, RM; Waisberg, DR | 1 |
| Balevic, S; Chu, V; Clark, R; Crenshaw, EG; Dallefeld, SH; Daniel, KR; Gilleskie, ML; Greenberg, RG; Kumar, KR; Smith, DS; Smith, PB; Zimmerman, KO | 1 |
1 trial(s) available for lorazepam and chloral hydrate
| Article | Year |
|---|---|
The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
Topics: Acute Disease; Adult; Antipsychotic Agents; Chloral Hydrate; Dopamine Antagonists; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Lorazepam; Male; Placebos; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Receptors, Dopamine D4; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome | 1997 |
5 other study(ies) available for lorazepam and chloral hydrate
| Article | Year |
|---|---|
Selectivity in the generalization profile in baboons trained to discriminate lorazepam: benzodiazepines, barbiturates and other sedative/anxiolytics.
Topics: Animals; Anti-Anxiety Agents; Chloral Hydrate; Chlormethiazole; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Psychological; Hypnotics and Sedatives; Lorazepam; Male; Meprobamate; Papio | 1997 |
Developmentally based care reduces stress levels in severely ill, very low birth weight (VLBW) infants, and thus decreases sedation requirements.
Topics: Chloral Hydrate; Conscious Sedation; Humans; Hypnotics and Sedatives; Infant, Newborn; Infant, Very Low Birth Weight; Lorazepam; Midazolam; Stress, Physiological | 1999 |
Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department.
Topics: Adjuvants, Anesthesia; Analgesia; Anesthetics, Combined; Child; Child, Preschool; Chloral Hydrate; Conscious Sedation; Diazepam; Emergency Treatment; Fasting; Fentanyl; Guideline Adherence; Humans; Hypnotics and Sedatives; Hypotension; Hypoxia; Ketamine; Laryngismus; Lorazepam; Midazolam; Nitrous Oxide; Patient Selection; Pediatrics; Pentobarbital; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vomiting | 2003 |
Withdrawal treatment with clonidine after prolonged use of chloral hydrate in a pediatric intensive care patient.
Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Chloral Hydrate; Clonidine; Fentanyl; Humans; Hypnotics and Sedatives; Infant; Intensive Care, Neonatal; Lorazepam; Male; Methadone; Midazolam; Pneumonia; Respiratory Insufficiency; Substance Withdrawal Syndrome | 2011 |
Comparative safety profile of chloral hydrate versus other sedatives for procedural sedation in hospitalized infants.
Topics: Chloral Hydrate; Diagnostic Imaging; Diagnostic Techniques, Ophthalmological; Electroencephalography; Female; Gestational Age; Hospitalization; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Logistic Models; Lorazepam; Male; Midazolam; Multivariate Analysis; Oxygen Inhalation Therapy; Pentobarbital; Polysomnography; Propensity Score; Respiration, Artificial; Respiratory Insufficiency | 2020 |